SCHEMBL441286

SCHEMBL441286

C[C@H]1CC[C@@H](O)CC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11799 1.00
SCHEMBL178952 1.00
Ethane SCHEMBL27625986 0.96 TSHR (0.41)
Methyl Alcohol SCHEMBL27464623 0.96 TSHR (0.41)
SCHEMBL2612208 0.90 TSHR (0.37)
Propane SCHEMBL28218331 0.90 SHBG (0.46)
SCHEMBL16248250 0.90 TSHR (0.37)
SCHEMBL14318801 0.90 TSHR (0.37)
SCHEMBL1006983 0.87
SCHEMBL4847697 0.87 TSHR (0.59)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 274 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-102477014-B The preparation method of Peremin SHANDONG NEW TIME PHARMACEUTICAL Co.,Ltd. (CN) 2015-08-19 CN claimed
CN-102477014-A Preparation method of histamine dihydrochloride SHANGDONG NEW TIME PHARM PROD 2012-05-30 CN claimed
WO-2025125665-A1 FURTHER SUBSTITUTED IMIDAZOLES AS INHIBITORS OF NAV1.8 Grünenthal GmbH (DE) 2025-06-19 WO disclosed
CN-119767902-A Color conversion film, light-emitting device and preparation method of light-emitting device 广东聚华印刷显示技术有限公司 2025-04-04 CN disclosed
US-20240410055-A1 METHOD AND FORMULATION FOR PREPARING OPTICAL METAL OXIDE LAYERS MERCK PATENT GMBH (DE) 2024-12-12 US disclosed
US-20240239790-A1 7-Morpholino-1,6-Naphthyridin-5-yl Derivatives and Pharmaceutical Compositions Thereof Useful as DNA-PK Inhibitor LIFEARC (GB) 2024-07-18 US disclosed
WO-2024148087-A1 CDK2 INHIBITORS BLUEPRINT MEDICINES CORPORATION (US) 2024-07-11 WO disclosed
WO-2024148091-A1 CDK2 INHIBITORS BLUEPRINT MEDICINES CORPORATION (US) 2024-07-11 WO disclosed
CN-118076767-A Method and formulation for producing an optical metal oxide layer 默克专利有限公司 2024-05-24 CN disclosed
US-20230322791-A1 CDK2 INHIBITORS BLUEPRINT MEDICINES CORPORATION 2023-10-12 US disclosed
US-11780851-B2 LRRK2 inhibitors H. LUNDBECK A/S (DK) 2023-10-10 US disclosed
WO-2002024663-A2 PYRIMIDINE COMPOUNDS AND THEIR USE SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2002-03-28 WO disclosed
US-5298609-A Light stable yellow pigments for polyolefins CIBA-GEIGY CORPORATION (US) 1994-03-29 US disclosed
EP-0523005-A2 Disazodyes with cycloalkylester or cycloalkylamide rests CIBA-GEIGY AG (CH) 1993-01-13 EP disclosed
US-4816452-A ANTIBIOTICS BEECHAM GROUP P.L.C. (GB) 1989-03-28 US disclosed
EP-0100906-B1 TRI- AND TETRACYCLIC IMIDAZO(1,5-A)(1,4)BENZODIAZEPIN-1-CARBOXYLIC-ACID DERIVATIVES F. HOFFMANN-LA ROCHE & CO. Aktiengesellschaft (CH) 1987-05-13 EP disclosed
EP-0210815-A2 6-Beta-(alpha-etherified oxyimino)-acylamino penicillanic-acid derivatives, their preparation and use BEECHAM GROUP PLC (GB) 1987-02-04 EP disclosed
US-4489003-A ANTICONVULSANTS, TRANQUILLIZERS HOFFMANN-LA ROCHE INC. (US) 1984-12-18 US disclosed
EP-0100906-A2 Tri- and tetracyclic imidazo(1,5-a)(1,4)benzodiazepin-1-carboxylic-acid derivatives F. HOFFMANN-LA ROCHE & CO. Aktiengesellschaft (CH) 1984-02-22 EP disclosed
US-4290961-A Process for catalytically reducing carbonyl compounds MONTEDISON S.P.A. (IT) 1981-09-22 US disclosed